Loading...
Fidelity Disruptive Medicine Fund
FMEDX•NASDAQ
Financial ServicesAsset Management
$11.28
$-0.02(-0.18%)
Fidelity Disruptive Medicine Fund (FMEDX) Stock Overview
Explore Fidelity Disruptive Medicine Fund’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for FMEDXStats details for FMEDX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for FMEDXAnalyst Recommendations details for FMEDX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Normally the fund invests at least 80% of assets in securities of disruptive medicine companies. Normally it invests primarily in equity securities. Companies within the disruptive medicine theme include but are not limited to those companies that, in the Adviser's opinion, are engaged in robotic surgery, gene therapy, genomics, rare diseases, medical devices and equipment, immunotherapy, technology-based health care platforms, and consumer wellness. The fund is non-diversified.
Headquarters
MA
Founded
2020